Analyst Ratings for Novavax (NVAX)
NVAX Rating Summary
NVAX Price Target Summary
- Highest: $18.00 (Cantor Fitzgerald)
- Lowest: $6.00 (Citi)
- Average: $11.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$11.00 (+10.2%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
Avg. $ Target:
$11.00 (+10.2%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/24/2025 | Cantor Fitzgerald » Updated 1/13/2026 |
Pete Stavropoulos | New Coverage | Overweight (N/A) |
18.00 (N/A) |
8.36 (9.98) |
19.38% | Details |
| 8/28/2025 | H.C. Wainwright » Updated 2/27/2026 |
Sean Lee | New Coverage | Buy (N/A) |
16.00 (11.00) |
7.58 (9.98) |
31.66% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
